Breaking

Wildfires sweep through forests in drought-hit Syrian coast in major test for new government
Tech 5: US Lifts EDA Restrictions for China, Apple Explores Third Party AI for Siri
Dalai Lama marks his 90th birthday as crowds throng his home-in-exile
Calls are mounting to ban Germany’s far-right AfD party – despite it being more popular than ever
For the first time, Xi is missing a China-backed BRICS summit. Why?
Iran’s supreme leader appears in public for first time since start of conflict with Israel
Ukraine says it struck a Russian air base as Moscow sent hundreds of drones into Kyiv
Japan braces for more quakes, authorities dismiss doomsday hype

Facebook
Twitter
Google Plus
Instagram
Pinterest
Vimeo

Investing
Stock
Latest News
Editor’s Pick
Economy
Search for:

Investing

New RAD202 data confirms positive tumor uptake

By March 17, 2025

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced New RAD202 data confirms positive tumor uptake

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Tech 5: US Lifts EDA Restrictions for China, Apple Explores Third Party AI for Siri

Stallion Uranium to Resume Trading on the TSX-V and Enters into Agreement to Sell Shares of 1503571 B.C. LTD.

Top 5 Canadian Mining Stocks This Week: Mkango Gains 90 Percent on Spin-out News

Enter Your Information Below To Receive Latest News, And Articles.
Your name

Your email
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest Posts
Categories
- Economy (906)
- Editor's Pick (485)
- Investing (3,487)
- Latest News (3,505)
- Stock (1,161)
About Rightinvestingway

Disclaimer: Rightinvestingway.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 Rightinvestingway.com

Top

Type above and press Enter to search. Press Esc to cancel.